Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    3363593 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease
Condition: West Nile Virus
Intervention: Drug: Omr-IgG-am
2 Not yet recruiting Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis Trial
Condition: Ischemic Stroke
Intervention: Drug: apixisaban
3 Active, not recruiting PERIOP 2 - A Safety and Effectiveness Study of LMWH Bridging Therapy Versus Placebo Bridging Therapy for Patients on Long Term Warfarin and Require Temporary Interruption of Their Warfarin.
Condition: Stroke
Interventions: Drug: Dalteparin;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.